| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |